PYRO (Postdoctoral and Young Researcher Organization) and NCMM (Centre for Molecular Medicine Norway) invite you to a webinar about national research infrastructures. The webinar will help early career (and established) scientists get an overview of potential platforms that can assist and enrich their research.
In our recovery from the COVID-19 pandemic we have experienced how essential cooperation in research and innovation is. Research Infrastructures (RIs) are facilities that provide resources and services for research communities to improve research, innovation, and collaboration (international). This webinar will give you the chance to learn about the activities of nine research infrastructures (RIs) that all provide services in medicine and life sciences. Some are centered around a specific technique or instrument; others provide education or networking opportunities or help with research proposals, data management, or clinical trials.
The webinar has been made possible with the help of EATRIS (European Infrastructure for Translational Medicine). EATRIS is a non-profit European Research Infrastructure Consortium (ERIC) that focuses on preclinical and early clinical development of medicinal products and diagnostics, and provides solutions in five platforms of expertise, namely Advanced Therapy Medicinal Products (ATMPs), Biomarkers, Imaging and Tracing, Small Molecules, and Vaccines.
|13:00||PYRO, Erik Knutsen - Welcome and intro|
|13:05||Norseq, Ruth H. Paulssen, Sequencing|
|13:15||PRiME, Sietske Grijseels - Proteomics and Metabolomics|
|13:25||Biobank Norway, Kristian Hveem - Biobank data|
|13:35||KAM /AMCF, Kenneth Bowitz Larsen - Advanced microscopy|
|13:45||Norbrain/viral core, Rajeevkumar Nair Raveendran - Viral vector tools for neuroscience and biomedicine|
|13:55||Short coffee break|
|14:10||Nor-Openscreen, Johannes Landskron - Chemical Biology, high throughput screening, bioprospecting|
|14:20||ELIXIR Norway, Christine Stansberg - Life science data|
|14:30||EATRIS Norway, Anita Kavlie, Research structure for translational medicine|
|14:40||NorCRIN, Berit Gravrok/Ingvild Pettersen - Clinical trials|
|14:50||Janna Saija Saarela, director NCMM - Conclusions, questions, and feedback|
After the webinar you will receive a contact list so you can get in touch with one or several RIs that you find interesting for follow up questions and to get the desired help.